Date change for webinar on new Stark FMV regs
Part 1 of a two-part BVR webinar series on the new Stark FMV regs, originally scheduled for June 28, will be held on July 26.
A Lesson in Healthcare Supply and Demand—and Market Power, Part 2
This is Part 2 of a two-part article that follows up on the author’s landmark research on the fair market value of physician compensation. The issue of insurance market structure and the related impact on the negotiating of provider contracts was addressed in Part 1 of this article. Physician distribution and the impact of local payment rates that determine compensation is addressed in Part 2.
A Lesson in Healthcare Supply and Demand—and Market Power, Part 1
This is a follow-up to the author’s landmark research on the fair market value of physician compensation. The issue of insurance market structure and the related impact on the negotiating of provider contracts is addressed in Part 1 of this article. Physician distribution and the impact of local payment rates that determine compensation is addressed in Part 2.
BV News and Trends April 2022
A monthly roundup of key developments of interest to business valuation experts.
Weaver reviews healthcare valuation in 2021
A collection of articles by valuation practitioners at Weaver give a 2021 year in review for healthcare valuations.
BV News and Trends January 2021
A monthly roundup of key developments of interest to business valuation experts.
Imaging centers: If you’ve seen one, you haven’t seen them all
If you value the local hardware store, the next one you value is likely to look pretty much the same.
Physician Distribution, Mobility, Fair Market Value, and Compensation Surveys: An Update
This article updates the author’s peer-reviewed research on the geographic distribution of physicians in the United States, including some key commentary from CMS about the use of surveys for Stark fair market value.
The Myth of the Healthcare Multiple
For most, the concept of a valuation multiple is easy for market participants to understand. Unfortunately, this simplicity of concept leads to widespread misapplication of valuation multiples and often results in sellers having unreasonable expectations. In the myth of the multiple, healthcare valuation expert Jason Ruchaber, CFA, ASA, will separate fact from fiction and explore the real financial and compliance considerations that drive FMV and purchase price in healthcare transactions.
‘Survey Says’ for FMV of Physician Compensation Is on Its Last Legs
The use of compensation surveys to determine the fair market value of physician compensation is seriously flawed, a position well-known expert Mark Dietrich has long maintained. Plus, recent government regulations confirm his position. He offers an alternate methodology.
BV News and Trends November 2021
A monthly roundup of key developments of interest to business valuation experts.
Dietrich updates landmark research on physician compensation
The December issue of Business Valuation Update includes an article by Mark Dietrich that updates his important research on the geographic distribution of physicians in the United States.
BV News and Trends October 2021
A monthly roundup of key developments of interest to business valuation experts.
D&P/Kroll updates multiples in healthcare services
The S&P Healthcare Services Index declined by 0.6% in August, compared to the S&P 500 Index, which increased 2.9% over the same period, according to the August 2021 “Healthcare Services Sector Update” from Duff & Phelps, a Kroll Business.
Specialty pharmacies resilient amid COVID-19
The pandemic had less of an impact on specialty pharmacies than other types of entities, say speakers on a recent BVR webinar.
New rules for FMV in healthcare should dull DOJ’s sword
The Department of Justice has taken an aggressive stance in fraud and abuse cases involving the measurement of fair market value of physician compensation.
New Ballgame for FMV in Healthcare Under Final CMS Rules
The valuation profession is now in the driver’s seat with respect to the definition of fair market value for healthcare regulatory purposes. The game changer is in the final rules from the Centers for Medicare & Medicaid Services (CMS) related to the Stark Law. There is also a call for papers.
Call for papers: New Stark regs and healthcare valuation
We here at BVR are putting together a special report on the revised definition of fair market value (FMV) for the Stark regulations.
BV News and Trends May 2021
A monthly roundup of key developments of interest to business valuation experts.
BVU News and Trends April 2021
A monthly roundup of key developments of interest to business valuation experts.
Tomorrow is the deadline for proposals for healthcare papers
April 15 is the deadline for proposals for papers on issues of fair market value, general market value, and commercial reasonableness under the new Stark regulations.
Deadline looms for papers on new Stark regs and healthcare valuation
April 15 is the deadline for proposals for papers on issues of fair market value, general market value, and commercial reasonableness under the new Stark regulations.
April 15 deadline for call for papers on new Stark regs and healthcare valuation
BVR is seeking proposals for papers on issues of fair market value, general market value, and commercial reasonableness under the new Stark regulations.
New association formed for healthcare compensation pros
The American Association of Provider Compensation Professionals (AAPCP) is a new nonprofit group whose members advise and lead healthcare organizations on provider compensation, contracting, planning, recruitment, retention, strategy, and, yes, valuation.
Call for papers: New Stark regs and healthcare valuation
Recent regulatory changes will have a significant impact on valuations in the healthcare sector, and BVR is developing content designed to help practitioners navigate the new rules.